“Proposed US government funding plans include $10m the FDA will use to increase oversight of drug manufacturing and research in China.”
http://www.biopharma-reporter.com/Bio-Developments/US-FDA-10M-in-CR-to-Add-More-Capacity-in-China-for-Inspections
